Evaluation of Professional Practices in the Treatment of Refractory Idiopathic Overactive Bladder at the Dose of 50 Units (TOX50IUU)

NCT04075578 · clinicaltrials.gov ↗

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Bladder, Overactive

Interventions

DRUG: OnabotulinumtoxinA / Botox®, Allergan Ltd, Irvine, CA, United-States

Sponsor

University Hospital, Clermont-Ferrand